Ocular Pathobiology Scientific Interest Group (SIG)

Ocular SIG

Our mission is to advance our understanding in the cellular and molecular mechanisms of common and rare ocular diseases. Research in ocular pathobiology crosses a wide range of fields, including but not limited to inflammation, neurodegeneration, angiogenesis/vascular dysfunction, immunology, metabolism, ophthalmic imaging, machine learning, neuroprotection, gene therapy, stem cell biology, and regeneration. We aim to engage an active community of basic scientists and clinicians, to promote novel clinical, mechanistic, and translational research, to create a platform for exchange of ideas, development and strengthening of collaborations, dissemination of scientific knowledge, and to foster the growth of the next generation of ocular researchers through inspiring mentoring and education.

As a result of the aging of the world population and the increase in obesity and metabolic disorders, the prevalence of ocular diseases and associated visual impairment is rising rapidly. In the US alone, age-related macular degeneration affects close to 3 million people, > 2 million are diagnosed with glaucoma and > 6 million patients. These numbers are estimated to double or triple by 2050. In addition, there more than 250 inherited retinal disorders that constitute the most common cause of blindness for ages 20-45.

The objectives of the ASIP Ocular Pathobiology SIG are:

  1. To engage an active community of biologists, clinician scientists and trainees who share an interest in ocular disorders and diseases
  2.  To provide a platform for discussion, for the exchange of ideas on current topics, cutting-edge technologies, and innovation, for networking and career development
  3. To support scientific communication and outreach by organizing and sponsoring relevant scientific sessions at the ASIP annual meeting and webinars
  4. To promote the engagement and the professional growth of students and trainees within the ocular research field through dedicated social events and mentoring opportunities

Listserv

ASIP Members are invited to participate in the Ocular Pathobiology SIG Listserv. Please email membership@asip.org to have your name and email address added to the listserv. To send a message to the Ocular Pathobiology SIG Listserv, send your email to asipocular@asip.memberclicks.net. Please note that you must be a member of this listserv in order to send and receive messages.

 More Information on ASIP.ORG


Leadership

Magali Saint-Geniez, PhD

Magali Saint-Geniez, PhD
Schepens Eye Research Institute of Mass. Eye and Ear
Department of Ophthalmology
Harvard Medical School
Boston, MA

magali_saintgeniez@meei.harvard.edu

Patricia A. D’Amore, PhD, MBA

Patricia A. D’Amore, PhD, MBA
Schepens Eye Research Institute of Mass. Eye and Ear
Department of Ophthalmology
Harvard Medical School
Boston, MA

patricia_damore@meei.harvard.edu

Pathology in Biotech and Industry Scientific Interest Group (SIG)

Pathology in Biotech and Industry is a new community within the membership of the American Society for Investigative Pathology (ASIP) that is engaged in the science and focused on the issues that face pathologists, scientists, technicians, and those in training who are working in or considering working in the biotech and pharmaceutical industries. 


Our two-fold mission includes:

  1. providing a forum for showcasing new and developing scientific findings, methods, technologies, and tools from the worlds of biotechnology and drug development, and
  2. establishing a community committed to recognizing members’ scientific achievements and devoted to fostering the development and advancement of pathology careers in the biotechnology and pharmaceutical industries. 

Pathology in Biotech and Industry will provide innovative opportunities for productive networking, development of meaningful professional partnerships, and mentoring.

Dr. Cary Austin
Genentech Research Pathology

Dr. Shawn O’Neil
Pfizer Global Pathology & Investigative Toxicology

ASIP members from any membership category (Regular, NextGen, Trainee, etc.) who are involved in the biotechnology & pharmaceutical industries or those interested in opportunities in industry are eligible for membership and encouraged to join. If you are a current ASIP member and would like to join, please email Lisa McFadden. Otherwise, you can elect to join Pathology in Biotech and Industry when you renew your membership. Pathology in Biotech and Industry will have a presence on the ASIP website and will contribute to our scientific meetings by co-organizing scientific sessions (in conjunction with various Scientific Interest Groups), as well as educational and career development events (in conjunction with the Committee for Career Development and the Education Committee). We also look forward to the development of various programs to recognize the research achievements and promote career progression of ASIP members affiliated with Pathology in Biotech and Industry SIG.

More Information on ASIP.ORG